You are here: All Products  > InnoCare and Keymed Approved to Start Trials of CD20xCD3 Bispecific

InnoCare and Keymed Approved to Start Trials of CD20xCD3 Bispecific

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products